361 related articles for article (PubMed ID: 29603764)
21. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
[TBL] [Abstract][Full Text] [Related]
22. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
[TBL] [Abstract][Full Text] [Related]
23. Endocrine Evaluation in POEMS Syndrome: A Cohort Study.
Yang H; Zhao H; Gao X; Huang X; Cao X; Zhou D; Xia W; Li J
Front Endocrinol (Lausanne); 2020; 11():536241. PubMed ID: 33193075
[TBL] [Abstract][Full Text] [Related]
24. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome.
Wang C; Huang XF; Cai QQ; Cao XX; Cai H; Zhou D; Li J
Leuk Res; 2016 Nov; 50():78-84. PubMed ID: 27697660
[TBL] [Abstract][Full Text] [Related]
25. A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea.
Kook HW; Jang JE; Min CK; Yoon DH; Kim K; Bang SM; Park Y; Lee JH; Yoon SS; Kim JS
J Korean Med Sci; 2024 Jan; 39(2):e5. PubMed ID: 38225781
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
Taenaka R; Shimokawa S; Katayama A; Nagao T; Obara T; Nishimura N; Tsujimoto A; Kohno K; Aoki K; Ogawa R
J Med Case Rep; 2022 Aug; 16(1):311. PubMed ID: 35978379
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Outcomes of Autologous Stem Cell Transplantation in Patients with Newly Diagnosed POEMS Syndrome.
Li AA; Gao XM; Zhao H; Shen KN; Zhang L; Cao XX; Li J
Transplant Cell Ther; 2024 Feb; 30(2):207.e1-207.e7. PubMed ID: 37931801
[TBL] [Abstract][Full Text] [Related]
28. Living with Polyneuropathy Organomegaly Endocrinopathy Monoclonal gammopathy Skin changes (POEMS) syndrome: a case study of healthcare experiences and quality of life.
Twigg J; Methley A; Lavin T; Dickinson G; Teager A
Disabil Rehabil; 2021 Aug; 43(17):2502-2510. PubMed ID: 31838877
[TBL] [Abstract][Full Text] [Related]
29. Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature.
Zeng K; Yang JR; Li J; Wei Q; Yang YM; Liu T; Niu T
Acta Haematol; 2013; 129(2):101-5. PubMed ID: 23171959
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
31. Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone.
Ikeda S; Kobayashi T; Saito M; Komatsuda A; Ubukawa K; Kameoka Y; Takahashi N
Intern Med; 2019 Dec; 58(23):3461-3468. PubMed ID: 31391391
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients.
Fang F; Lan XX; Hu RH; Hui WH; Zhao H; Guo YX; Ji BX; Liu HJ; Su L; Sun WL
Ther Adv Neurol Disord; 2024; 17():17562864231219151. PubMed ID: 38288324
[TBL] [Abstract][Full Text] [Related]
33. Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.
Zagouri F; Kastritis E; Gavriatopoulou M; Sergentanis TN; Psaltopoulou T; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2014 Sep; 55(9):2018-23. PubMed ID: 24295131
[TBL] [Abstract][Full Text] [Related]
34. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
[TBL] [Abstract][Full Text] [Related]
35. Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.
Cai QQ; Gao XM; Le J; Zhao H; Cai H; Cao XX; Li J
Ann Hematol; 2021 Jun; 100(6):1547-1552. PubMed ID: 33839882
[TBL] [Abstract][Full Text] [Related]
36. Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review.
Kubota Y; Hanaoka Y; Koyama JI; Takahashi Y; Katoh N; Iwaya M; Fujii Y; Ogiwara T; Horiuchi T
Nagoya J Med Sci; 2023 Feb; 85(1):141-149. PubMed ID: 36923610
[TBL] [Abstract][Full Text] [Related]
37. [POEMS syndrome. An interdisciplinary clinical challenge].
Braun SA; Albrecht P; Methner A; Hanneken S
Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
[TBL] [Abstract][Full Text] [Related]
39. Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.
Yang H; Zhao H; Huang X; Cao X; Zhou D; Li J
Leuk Lymphoma; 2019 Feb; 60(2):483-487. PubMed ID: 30407096
[TBL] [Abstract][Full Text] [Related]
40. Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome.
Li J; Duan MH; Wang C; Huang XF; Zhang W; Cao XX; Zhu TN; Zhuang JL; Han B; Cai H; Cai HC; Zhou DB
Leukemia; 2017 Jun; 31(6):1375-1381. PubMed ID: 28100909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]